-+ 0.00%
-+ 0.00%
-+ 0.00%

ALVOTECH ANNOUNCES APPROVAL OF AVT03, A BIOSIMILAR TO PROLIA® AND XGEVA® (DENOSUMAB) IN THE EUROPEAN ECONOMIC AREA

Reuters·11/24/2025 10:30:00

Please log in to view news